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Febrile convulsions (FC) are the most common convulsive events in childhood, 
occurring in 2-5% of children. About one third of these children will have 
a recurrence during a subsequent febrile infection. This sudden neurologic 
problem is extremely frightening and emotionally traumatic for parents so some 
physicians try to prevent recurrence of FC by prescribing different drugs.
Materials and Methods
This is a randomized clinical trial in 85 healthy children, aged 6 months to 5 
years, who were not treated before. These children received randomly either 
oral diazepam (0.33 mg/kg/TDS for two days during febrile illness) or continuous 
oral Phenobarbital (3-5mg/kg /24 h). 
Results
Ultimately 64 patients completed the study and were followed up for an average 
of 13 months (12-18 months). The rate of recurrence of febrile seizure was 18.2% 
in diazepam group and 32.3% in Phenobarbital group; the difference is not 
statistically significant (p=0.16). 
Conclusion
There was no significant difference between intermittent oral diazepam and 
continuous oral Phenobarbital for FC prevention.
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Introduction
Febrile seizures are defined as seizures that occur in association with a fever in 
children 6 months to 5 years of age, but in whom there is no evidence of a central 
nervous system infection or another definable cause of seizure, and which are not 
preceded by a history of an afebrile seizure (1, 2). Febrile seizures are classified as 
simple or complex. Simple febrile seizures account for approximately 85% of all 
febrile seizure. A complex seizure usually lasts longer than 15 minutes, is focal, 
might recur within the same day, and might have either a prolonged period of 
postictal drowsiness or be associated with postictal neurologic abnormalities(3).
Although febrile seizures are benign and the neurologic outcome is excellent, this 
sudden neurologic problem is extremely frightening and emotionally traumatic 
for parents who sometimes think their child might die during the seizure (4). 
Approximately 30% to 40% of children who experience a febrile seizure will have 
a recurrence, but less than 10% will have three or more recurrences (5). The good 
prognosis for most patients with febrile seizures reduces the need for continuous 
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prophylactic treatment with anticonvulsant agents, 
and intermittent prophylactic treatment seems to be a 
rational approach. Several studies have shown that daily 
administration of Phenobarbital (5 to 8 mg/kg/day for 
children 2 years of age and 3 to 5 mg/kg/ day for children 
_2 years of age) or valproic acid (10 to 15 mg/kg/day 
in divided doses) is effective to prevent febrile seizures 
(6, 7). Adverse effects of Phenobarbital include transient 
sleep disturbances, daytime drowsiness, fussiness, 
attention deficit, hyperactivity, decreased memory, 
and impaired cognitive function (8). Diazepam, when 
administered intermittently either rectally or orally 
in sufficient doses (0.3 to 0.5 mg/kg, maximum 10 
mg) at the onset of fever, has been shown to prevent 
recurrence of febrile seizures (9).A potential drawback 
of intermittent diazepam therapy is that some seizures 
occur before a fever is noticed (10). Adverse effects of 
diazepam therapy include lethargy, drowsiness, ataxia, 
dizziness, slurred speech, bradycardia, hypotension, and 
respiratory depression (11). 
Currently in Iran 2 methods are commonly practiced for 
prevention of febrile seizures:
1- Intermittent use of oral diazepam during intercurrent 
febrile illnesses.
2- Continuous daily administration of oral Phenobarbital 
for a period of time.
Each of these two methods has its own advantages 
and inconveniences. For example intermittent use of 
diazepam and lead to “fever phobia” in the parents and 
continuous use of Phenobarbital may cause transient 
decline in attention and behavioral problem in children.
The aim of this study was to evaluate the effectiveness 
of oral administration of diazepam in comparison with 
continuous oral Phenobarbital to reduce recurrence of 
febrile seizure in children.
Materials and Methods
This prospective study took place in Mofid children 
hospital for 2 years from September 2000 to December 
2001. The children with first febrile seizure were 
included if they were aged 6 months to 5 years; if they 
had no history of neurologic disease; and if only one of 
the following was true:
1-age less than 1 year at the time of the first seizure; 
2-body temperature less than 39 C during the spell;
3- Familial history of epilepsy in first degree relative.
The use of continuous prophylactic treatment in these 
cases could be justified regarding increased risk of FC 
recurrence. 
This study was a randomized trial of diazepam versus 
Phenobarbital. Treatment was prescribed and a written 
monitoring chart was explained to parents during 
hospitalization for the first seizure. Parents recorded 
the number of days with temperature greater than 38°C 
and the number of days of diazepam administration on a 
special sheet. They also recorded the child's acceptance 
of the treatment (easy, difficult). 
 The oral prophylaxis was one of the following:
A- Diazepam, according to the body weight of the child 
(0.33 mg/kg every 8 h), during each episode of fever, 
for 48 h.
B- Phenobarbital according to the body weight of the 
child (3-5 mg/kg, divided in two daily doses), during 1 
year.
A statistician randomly assigned each child to Group 
A or B and the doctors who followed these children 
did not know the randomization. A monthly telephone 
follow up is done for the purpose of ensuring parental 
compliance.
Comparison between two groups was analyzed by 
independent-sample t-tests for quantitative variables and 
the x 2 test for categorical variables. P values, 0.05 were 
considered statistically significant.
Results 
There were 85 children who met all the entry criteria. 21 
children were excluded because no follow-up information 
could be obtained after the initial evaluation. This report 
is, therefore, based on the remaining 64 children for 
whom a follow-up contact was made. 33 children were in 
Diazepam and 31 in Phenobarbital group. There was no 
difference in age, sex, family history of seizure and the 
characteristics of the first seizure between the Diazepam 
and Phenobarbital groups (Table I).
The follow up time was between 12-18 months. The 
mean follow up time in Diazepam and Phenobarbital 
group was 12.6 and 13.7 months respectively, and there 
is no significant difference between two groups.
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6 children (18.2%) in the diazepam group and 10 (32.3%) 
in the placebo group, had a recurrence (difference not 
significant, P=0.16). risk assessment with other variables 
(age, seizure type, ) did not show significant results.
Discussion 
The aim of this study was to compose two common 
clinical practices of Iranian physicians for prevention of 
recurrence of febrile seizure. One of the most important 
results of this research is that none of these methods can 
definitely stop febrile seizure reappearance. Although 
numerically febrile seizure recurrence was less in children 
who received diazepam intermittently but statistically no 
difference existed between these two groups.
We didn’t find in our literature review any study who 
compared these two drugs; indeed in several trials 
diazepam and Phenobarbital; alone or in comparison 
with other methods for febrile convulsion prophylaxis, 
were studied(12, 13, 14, 15, 16, 17, 18).
In a double blind randomized trial of diazepam versus 
placebo for febrile seizure prevention Antrent and his 
colleagues didn’t find any difference between the two 
groups(12).
But as the authors stated the major problem was 
noncompliance in the case group of some families made 
the results unreliable. Rosemane find 82% decrease in 
probability of febrile seizure recurrence in children who 
used diazepam versus placebo in a controled trial(13) . 
In a more recent study performed by Verrotti et al in Italy 
recurrent febrile seizure occurred in 11.1% of children 
who used diazepam intermittently versus 30.7% in those 
who didn’t take any medication (16) All of these authors 
mentioned about some inconvenience of this method, the 
most important, being late administration of diazepam 
by parents several hours after start of fever. Lethargy, 
Ataxia and hypotonia are some relatively common side 
effects.
Rose W. et al in a controlled trial done in India concluded 
that intermittent clobazam can be as effective as diazepam 
and with lower side effects as ataxia (19).
When phenobarbital is being used continuously there 
is no fear of sudden emergent fever which can be 
ignored by parents, as in diazepam group; because a 
long standing therapeutic drug level is already achieved 
which can prevent seizure. The main problem when 
prescribing phenobarbital is family noncompliance and 
mild cognitive impairment in long term use (20).
Mamelle and Ngware in 2 separate randomized 
therapeutic assays confirmed the efficacy of continuous 
Phenobarbital usage with a dose 4-5 mg/kg daily for 
prevention of febrile seizure (14, 15). One of the strength 
of this study was serum Phenobarbital assays in children 
who received it. Such measurement could easily separate 
noncompliant cases from those received Phenobarbital 
regularly with appropriate dosage.
Overall there is 20%-30% rate of FC recurrence 
regardless of with risk factors (17) .Previous studies using 
Phenobarbital reported an average decrease recurrence 
of 4% 13%(15, 20) . In our study we found 32% 
recurrence rate of F.C, which seems to be similar to the 
natural course of the disease (without any intervention).
The explanation is that our patients had at least one risk 
factor of FC recurrence and sometimes two or three. 
Indeed the 20-30% recurrence rate is irrespective of 
having or not any risk factor. We did not measured serum 
Phenobarbital level in our patients, so the problem of 
Table 1: Characteristics of children (age, sex, family history of FC & epilepsy and type of FC) in the two groups 




 Phenobarbital group 31
children
P Value
Age (months/SD) 23.7 /13.4 23 /13.4   NS*
Sex (M/F) 10/3 18/1 NS
Familial febrile seizure (%) 19 (57.6%) 13 (41.9%) NS
Familial non febrile seizure(%) 3 (9.1%) 2 (6.6%) NS
Complex seizure 1 4 NS
 *NS: Not significant
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family non compliance remains an important factor 
explaining such relatively high rate of recurrence.
Negative effects of Phenobarbital on behavior and 
cognition restrict its daily usage in many countries (8-
9). 
In our literature review we didn’t find similar designed 
study comparing these two methods, but each practice 
had shown its efficacy for reducing FC recurrence (14-
17). Regarding the visible difference between these two 
methods a double blind trial could not be designed.
Two limitation of our study was first relatively short 
time of follow up and secondly not measuring serum 
Phenobarbital level, which should be applied in future 
researches on this issue. Regarding cognitive side effects 
of Phenobarbital, if a physician has planed drug therapy 
for FC prevention, we recommend intermittent diazepam 
during febrile illnesses.
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